PNC Financial Services Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,156
Closed -$424K 4804
2023
Q2
$424K Buy
4,156
+60
+1% +$6.12K ﹤0.01% 1679
2023
Q1
$372K Sell
4,096
-69
-2% -$6.27K ﹤0.01% 1736
2022
Q4
$158K Buy
4,165
+69
+2% +$2.62K ﹤0.01% 2282
2022
Q3
$103K Sell
4,096
-6
-0.1% -$151 ﹤0.01% 2520
2022
Q2
$124K Buy
4,102
+60
+1% +$1.81K ﹤0.01% 2423
2022
Q1
$132K Sell
4,042
-63
-2% -$2.06K ﹤0.01% 2536
2021
Q4
$108K Sell
4,105
-6,007
-59% -$158K ﹤0.01% 2640
2021
Q3
$1.02M Sell
10,112
-14
-0.1% -$1.41K ﹤0.01% 1183
2021
Q2
$1.43M Sell
10,126
-68
-0.7% -$9.62K ﹤0.01% 1049
2021
Q1
$1.02M Sell
10,194
-10
-0.1% -$996 ﹤0.01% 1152
2020
Q4
$1.26M Buy
10,204
+33
+0.3% +$4.08K ﹤0.01% 1026
2020
Q3
$990K Sell
10,171
-917
-8% -$89.3K ﹤0.01% 1051
2020
Q2
$1.73M Sell
11,088
-258
-2% -$40.3K ﹤0.01% 829
2020
Q1
$1.64M Buy
11,346
+300
+3% +$43.3K ﹤0.01% 786
2019
Q4
$2.26M Buy
11,046
+982
+10% +$201K ﹤0.01% 781
2019
Q3
$808K Sell
10,064
-24
-0.2% -$1.93K ﹤0.01% 1354
2019
Q2
$952K Hold
10,088
﹤0.01% 1304
2019
Q1
$862K Buy
10,088
+39
+0.4% +$3.33K ﹤0.01% 1355
2018
Q4
$565K Buy
10,049
+11
+0.1% +$618 ﹤0.01% 1492
2018
Q3
$820K Hold
10,038
﹤0.01% 1430
2018
Q2
$352K Hold
10,038
﹤0.01% 1858
2018
Q1
$206K Hold
10,038
﹤0.01% 2151
2017
Q4
$284K Buy
10,038
+38
+0.4% +$1.08K ﹤0.01% 1990
2017
Q3
$312K Hold
10,000
﹤0.01% 1890
2017
Q2
$316K Hold
10,000
﹤0.01% 1862
2017
Q1
$226K Hold
10,000
﹤0.01% 2068
2016
Q4
$218K Hold
10,000
﹤0.01% 2068
2016
Q3
$264K Hold
10,000
﹤0.01% 1932
2016
Q2
$198K Buy
+10,000
New +$198K ﹤0.01% 2091